Novo Nordisk A/S

Industry / private company


Location: Kopenhagen (Copenhagen), Denmark (DK) DK

ISNI: 0000000403912646

ROR: https://ror.org/0435rc536

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022 (2026) Martin S, Kyosovska-Peshtenska G, Audi J, Zarakowska K, Grauman Å, Veldwijk J, Hauber B, et al. Journal article, Review article Effect of semaglutide on COVID-19 and other infections: an analysis from the FLOW randomized clinical trial (2026) Rayner B, Mahaffey KW, Mann JF, Pratley RE, Rossing P, Belmar N, Bosch-Traberg H, et al. Journal article Kidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease (2026) Tuttle KR, Bakris GL, Baeres FM, Bang CN, Bax WA, Belmar N, Musinga D, et al. Journal article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial. Diabetes Care 2026;49:257–265 (2026) Mann JF, Jeppesen OK, Belmar N, McGuire DK, Buse JB Journal article Safety of Semaglutide After Dialysis Initiation: An Individual-Level Pooled Analysis (2026) Klein KR, Menacher A, Buse JB, Mann J, Tuttle KR, Kvist K, Andersen MR, et al. Journal article Nuances in Interpretation: Assessing the Interaction Between Semaglutide and MRAs in the FLOW Trial (2026) Rossing P, Perkovic V, Rasmussen S, Mann J Journal article Effect of Oral Semaglutide on Cardiovascular Outcomes in Type 2 Diabetes by Extent of Vascular Disease (2026) Cavender MA, Marx N, Mulvagh SL, Deanfield JE, Buse JB, Inzucchi SE, Pop-Busui R, et al. Journal article Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial (2026) Mann JF, Marx N, Deanfield JE, Emerson SS, Inzucchi SE, McGuire DK, Mulvagh SL, et al. Journal article Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026) Pop-Busui R, Rasmussen S, Deanfield JE, Buse JB, Marx N, Mulvagh SL, Inzucchi SE, et al. Journal article Response to the letter to the editor entitled “Semaglutide and kidney function: direct kidney protection or an artifact?” (2025) Perkovic V, Tuttle KR, Rossing P, Mann JF, Idorn T Journal article